Skip to content

Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management

Basivertebral Nerve Block Performed in Conjunction With Vertebral Augmentation for Anesthesia

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04774029
Enrollment
10
Registered
2021-02-26
Start date
2020-01-10
Completion date
2020-05-01
Last updated
2021-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertebra Compression Fracture, Vertebral Compression, Vertebral Fracture

Keywords

Basivertebral nerve block, Vertebral augmentation, BVN block, Kyphoplasty, nerve block, compression fracture

Brief summary

The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.

Detailed description

Vertebral compression fractures secondary to osteoporosis can be treated with vertebral augmentation. Since intraprocedural pain is common during vertebral body endplate manipulation, these procedures are often carried out using conscious sedation or general anesthesia. Research has shown that the vertebral endplates are innervated by the basivertebral nerve, which has been successfully targeted via radiofrequency ablation to treat chronic vertebrogenic lower back pain. With this physiology in mind, the investigators will attempt to treated participants with vertebral compression using lidocaine-induced intraosseous basivertebral nerve block as the primary intraprocedural analgesia.

Interventions

PROCEDUREBasivertebral nerve block

Temporary intraosseous basivertebral nerve block using lidocaine

DRUGLidocaine induced basivertebral nerve block

Intraosseous lidocaine basivertebral nerve block

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age \>50 years old * Patient must have a diagnosis of osteoporosis on dual energy x-ray absorptiometry (DEXA), * Patient must have an acute or subacute single level vertebral compression fracture between T10 - L3 as confirmed via magnetic resonance imaging (MRI) or nuclear medicine bone scan, * Patient must have an initial pain score of greater than or equal to five using a standard 0-10 Visual Analog Scale subjective pain score upon initial consultation.

Exclusion criteria

* Pathologic compression fracture, such as due to metastatic disease * Age \>90 years old or \<50 years old * Pregnancy * Diagnosed Anxiety Disorder * Diagnosed Depression Disorder * Diagnosed Psychotic Disorder * Diagnosed Mental Disease Disorder * Diagnosed Parkinson's disease/other movement disorders/or cerebellar dysfunction * Eastern Cooperative Oncology Group (ECOG) score at baseline prior to compression fracture \>1 * Back Pain scores at time of initial consult \<5, using a standard Visual Analog Scale * Illicit drug dependence or abuse * Alcohol dependence or abuse

Design outcomes

Primary

MeasureTime frameDescription
One-week Post-procedure Satisfaction ScoreAt one-week post-procedure follow-up.Patients will be asked to rate their satisfaction using a subjective Likert scale of 1 - 4, at one week clinical follow-up. Satisfaction ratings were defined as follows: 1 = completely dissatisfied, 2 = dissatisfied, 3 = satisfied, 4 = very satisfied.
Pre-procedure Pain ScoreAt pre-procedure consultation.Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained upon preprocedural consultation.
Immediate Post-procedure Pain ScoreIn the immediate post-procedure period in recover.Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained immediately post-procedure.
One-week Post-procedure Pain ScoreAt one-week post procedure follow-up.Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained at one-week post-procedure follow-up in clinic.
Immediate Post-procedure Satisfaction ScoreAssessed at one-week post procedure follow-up.Patients will be asked to rate their satisfaction using a subjective Likert scale of 1 - 4, in the immediate post-procedure period during recovery. Satisfaction ratings were defined as follows: 1 = completely dissatisfied, 2 = dissatisfied, 3 = satisfied, 4 = very satisfied.

Secondary

MeasureTime frameDescription
Blood pressure disturbanceIntraprocedural\>20% change from baseline systolic or diastolic blood pressure as measured in mm of Mercury (mmHg)
Need for additional anesthesia or sedationIntraproceduralIntraprocedural monitoring for patient pain in real time during the procedure. Need for additional pain or sedative medication such as Fentanyl or Versed, at the discretion of the interventional radiologist performing the procedure.
Intraprocedural pain during balloon augmentationIntraproceduralSpecial attention to patient pain will be assessed during intraprocedural balloon augmentation, as this is often the most painful part of the procedure. Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. Additional routine monitoring of pain will take place during the procedure as carried out by the circulating nurse and by the interventional radiologist performing the procedure.
Heart rate disturbanceIntraprocedural\>20% change from baseline heart rate as measured in beats per minute (BPM)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026